Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Product Development

Discovery through perturbation: taking causality into your own hands 

A company’s experimental setup and scale shape the type of AI it uses and questions it can ask

October 11, 2024 11:01 PM UTC

Increasingly sophisticated human cell-based models are expanding the scope and relevance of wet lab experiments, with the most scalable systems best poised to leverage emerging AI methods that power the likes of ChatGPT. But companies looking to capitalize on this trend must navigate trade-offs in their choices of experimental and computational models.

Target discovery campaigns that start with experiments in human cells, organoids or tissue models can establish cause-and-effect relationships from the start, and give researchers control over input variables, such how samples are processed, and outputs such as signal density. Starting with observational patient data, by contrast, ensures patient-relevance but offers far less control...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article